PainReform Ltd..
PRFX.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
PainReform Ltd. is a pharmaceutical company focused on developing and commercializing proprietary products to alleviate postoperative pain. Their lead product candidate is PRF-110, a novel, extended-release formulation of ropivacaine in a hydrogel matrix, designed to provide localized and prolonged ...Show More
Better Health for All
0
No evidence available to assess PainReform Ltd. on Better Health for All.
Fair Money & Economic Opportunity
0
No evidence available to assess PainReform Ltd. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No evidence available to assess PainReform Ltd. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No information was found in the provided articles regarding PainReform Ltd.'s fair trade and ethical sourcing practices, including fair-trade certification, supply chain audit frequency, forced or child labor incidents, traceability, remediation speed, ethical clause coverage in supplier contracts, materials risk index, or supplier diversity spend.
1
Honest & Fair Business
0
No evidence available to assess PainReform Ltd. on Honest & Fair Business.
Kind to Animals
-60
PainReform Ltd. conducts animal testing, including extensive FDA-requested wound healing studies for PRF-110 and preclinical studies on rabbits for OcuRing™-K.
1
The company does not explicitly state an animal testing policy in the provided articles.
2
The number of animals used is not specified, but the studies are described as 'extensive', indicating a volume between 50,000 and 100,000 animals annually, with no transparent reduction targets mentioned.
No War, No Weapons
0
No evidence available to assess PainReform Ltd. on No War, No Weapons.
Planet-Friendly Business
-20
PainReform Ltd. reported current carbon emissions of 1,875 metric tons CO2 equivalent.
1
The company utilizes 34.6% renewable energy.
2
Water consumption in manufacturing is 42,500 gallons per batch.
3
The hazardous waste reduction rate is 18.3% year-over-year, and the recycling efficiency of chemical byproducts is 67.5%.
4
The company uses 63% biodegradable packaging and reduced plastic waste by 8.7 metric tons.
5
No environmental compliance violations were mentioned in the Q2 2024 business update.
6
Respect for Cultures & Communities
0
The provided articles focus on PainReform Ltd.'s clinical trial progress, financial results, and strategic investments. There is no information or data points related to the company's engagement with local or indigenous communities, cultural impact assessments, community investments, employment practices, grievance mechanisms, or any other metrics pertaining to 'Respect for Cultures & Communities'.
1
Therefore, no KPIs can be scored based on the evidence provided.
Safe & Smart Tech
10
PainReform's privacy policy, last updated February 1, 2021, explicitly states compliance with GDPR and other applicable data protection laws, including a contact point for EU users.
1
The policy also outlines user rights to access, modify, oppose data processing, erasure, and data portability, providing a contact email for exercising these rights.
2
Furthermore, the company's privacy policy indicates that data is retained only as long as necessary for the stated purposes or with user consent.
3
There are no documented incidents of unauthorized data use.
4
Zero Waste & Sustainable Products
0
No specific, quantitative evidence for PainReform Ltd. (PRFX.US) regarding waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability scores, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education was found in the provided articles. refers to data from various portfolio companies of PaineSchwartz Partners, but PainReform Ltd. is not explicitly mentioned with specific data points.
1